iPS cells: mapping the policy issues

Amy Zarzeczny; Christopher Scott; Insoo Hyun; Jami Bennett; Jennifer Chandler; Sophie Chargé; Heather Heine; Rosario Isasi; Kazuto Kato; Robin Lovell-Badge; Kelly McNagny; Duanqing Pei; Janet Rossant; Azim Surani; Patrick L Taylor; Ubaka Ogbogu; Timothy Caulfield

doi:10.1016/j.cell.2009.11.039

iPS cells: mapping the policy issues

Cell. 2009 Dec 11;139(6):1032-7. doi: 10.1016/j.cell.2009.11.039.

Authors

Amy Zarzeczny¹, Christopher Scott, Insoo Hyun, Jami Bennett, Jennifer Chandler, Sophie Chargé, Heather Heine, Rosario Isasi, Kazuto Kato, Robin Lovell-Badge, Kelly McNagny, Duanqing Pei, Janet Rossant, Azim Surani, Patrick L Taylor, Ubaka Ogbogu, Timothy Caulfield

Affiliation

¹ Health Law Institute, University of Alberta, Edmonton, Alberta T6G 2H5, Canada.

PMID: 20005794
DOI: 10.1016/j.cell.2009.11.039

Abstract

Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Biomedical Research*
Humans
Induced Pluripotent Stem Cells / cytology*
Public Policy
Stem Cell Transplantation*
Tissue Donors

Abstract

Publication types

MeSH terms

Grants and funding